ReShape Lifesciences (RSLS) Institutional Ownership → Biotech's Best Kept Secret: Potential 46,751% Gain (From Behind the Markets) (Ad) Free RSLS Stock Alerts $0.25 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for ReShape Lifesciences (NASDAQ:RSLS)CurrentInstitutional OwnershipPercentage22.06%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$63.54KNumber ofInstitutional Sellers(last 12 months)0 Get RSLS Insider Trade Alerts Want to know when executives and insiders are buying or selling ReShape Lifesciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RSLS Institutional Buying and Selling by Quarter Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. ReShape Lifesciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2023 Armistice Capital LLC188,000$64K0.0%N/A5.449% 5/11/2022 GSA Capital Partners LLP36,490$43K0.0%N/A0.196% 11/15/2021 Sassicaia Capital Advisers LLC10,000$29K0.1%N/A0.063% 8/17/2021 Armistice Capital LLC816,527$4.08M0.1%N/A24.447% 8/16/2021 State Street Corp109,999$550K0.0%N/A3.293% 8/13/2021 Alpine Global Management LLC17,000$85K0.0%N/A0.509% 8/13/2021 Geode Capital Management LLC23,277$116K0.0%N/A0.697% 8/13/2021 Vanguard Group Inc.51,120$256K0.0%N/A1.531% (Data available from 1/1/2016 forward) RSLS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RSLS shares? During the previous two years, the following institutional investors and hedge funds held shares of ReShape Lifesciences shares: Armistice Capital LLC ($64K).Learn more on RSLS's institutional investors. What percentage of ReShape Lifesciences stock is owned by institutional investors? 22.06% of ReShape Lifesciences stock is owned by institutional investors. Learn more on RSLS's institutional investor holdings. Which institutional investors have been buying ReShape Lifesciences stock? The following institutional investors have purchased ReShape Lifesciences stock in the last 24 months: Armistice Capital LLC ($188K). How much institutional buying is happening at ReShape Lifesciences? Institutional investors have bought a total of 188,000 shares in the last 24 months. This purchase volume represents approximately $63.54K in transactions. Related Companies: KALA Major Shareholders IRIX Major Shareholders ECOR Major Shareholders HOOK Major Shareholders VANI Major Shareholders EDAP Major Shareholders ABT Major Shareholders ISRG Major Shareholders SYK Major Shareholders BSX Major Shareholders This page (NASDAQ:RSLS) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReShape Lifesciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
